IL149211A0 - Improved mutation analysis of the nf1 gene - Google Patents

Improved mutation analysis of the nf1 gene

Info

Publication number
IL149211A0
IL149211A0 IL14921100A IL14921100A IL149211A0 IL 149211 A0 IL149211 A0 IL 149211A0 IL 14921100 A IL14921100 A IL 14921100A IL 14921100 A IL14921100 A IL 14921100A IL 149211 A0 IL149211 A0 IL 149211A0
Authority
IL
Israel
Prior art keywords
gene
mutation analysis
improved mutation
improved
analysis
Prior art date
Application number
IL14921100A
Other languages
English (en)
Original Assignee
Univ Gent
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Gent filed Critical Univ Gent
Publication of IL149211A0 publication Critical patent/IL149211A0/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/156Polymorphic or mutational markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
IL14921100A 1999-10-18 2000-10-18 Improved mutation analysis of the nf1 gene IL149211A0 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP99870216 1999-10-18
EP00870122 2000-06-05
US21192900P 2000-06-16 2000-06-16
PCT/EP2000/010255 WO2001029251A2 (en) 1999-10-18 2000-10-18 Improved mutation analysis of the nf1 gene

Publications (1)

Publication Number Publication Date
IL149211A0 true IL149211A0 (en) 2002-11-10

Family

ID=26074255

Family Applications (1)

Application Number Title Priority Date Filing Date
IL14921100A IL149211A0 (en) 1999-10-18 2000-10-18 Improved mutation analysis of the nf1 gene

Country Status (6)

Country Link
US (1) US20030134272A1 (ja)
EP (1) EP1255858A2 (ja)
JP (1) JP2003529335A (ja)
AU (1) AU1140101A (ja)
IL (1) IL149211A0 (ja)
WO (1) WO2001029251A2 (ja)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070148636A1 (en) * 2005-12-23 2007-06-28 Song Min-Sun Method, compositions and kits for preparation of nucleic acids
AU2010330688B2 (en) * 2009-12-09 2016-03-17 Ezygene Pty Ltd Hyperprimers
CN103045605B (zh) * 2012-12-26 2015-01-07 首都医科大学宣武医院 一种与脑血管狭窄有关的ⅰ型神经纤维瘤nf1基因突变核苷酸序列及其应用
AU2014244550B2 (en) * 2013-03-14 2018-11-01 Mylan Inc. Glatiramer acetate response biomarker mRNA potency assay
TWI717314B (zh) 2013-10-24 2021-02-01 美商麥蘭股份有限公司 供評估格拉默醋酸鹽製備物之免疫同一性用的人類t細胞株分析方法
CA2967027A1 (en) * 2014-11-12 2016-05-19 Recombinetics, Inc. Heterozygous modifications of tumor suppressor genes
CN106755399B (zh) * 2016-12-21 2019-11-15 杭州艾诺医学检验所有限公司 一种i型神经纤维瘤病致病突变基因及基于此突变基因的病因学诊断试剂
KR101925974B1 (ko) * 2017-04-05 2018-12-06 울산대학교 산학협력단 게놈 dna 기반의 장 pcr 프라이머 세트를 포함하는 신경섬유종증 진단용 조성물
CN109988824A (zh) * 2019-04-30 2019-07-09 明码(上海)生物科技有限公司 一种检测nf1基因外显子基因突变的引物及方法、试剂盒
CN110184275B (zh) * 2019-06-19 2021-06-04 中国人民解放军陆军军医大学第一附属医院 一种nf1新突变致病基因及应用和试剂盒
AU2020328511A1 (en) 2019-08-09 2022-03-03 Nutcracker Therapeutics, Inc. Methods and apparatuses for manufacturing for removing material from a therapeutic composition

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5605799A (en) * 1990-07-12 1997-02-25 University Of Utah Research Foundation Somatic mutations in neurofibromatosis type 1 gene in human tumors

Also Published As

Publication number Publication date
AU1140101A (en) 2001-04-30
WO2001029251A2 (en) 2001-04-26
JP2003529335A (ja) 2003-10-07
WO2001029251A8 (en) 2003-02-06
US20030134272A1 (en) 2003-07-17
WO2001029251A3 (en) 2002-08-01
EP1255858A2 (en) 2002-11-13

Similar Documents

Publication Publication Date Title
GB9904991D0 (en) Genetic screening
PL343599A1 (en) Genes controlling diseases
EP1077996A4 (en) GENE EDG3sb HUMAN
IL149211A0 (en) Improved mutation analysis of the nf1 gene
HK1031983A1 (en) Gene mutant animals
HK1049682B (zh) 內切-β-N-乙酰葡糖胺糖苷酶基因
AU6387000A (en) Serial analysis of genetic alterations
HUP0104046A3 (en) Adenovirus-mediated gene therapy
AU3178200A (en) Genetic analysis
HUP0105208A3 (en) Gene therapy-1
IL146332A0 (en) PrP-LIKE GENE
EP1174499A4 (en) NEW AMIDASE GENE
GB0025890D0 (en) Gene therapy
EP1215284A4 (en) TSG TYPE GENE
AU5052999A (en) Human ccr-2 gene polymorphisms
GB0406539D0 (en) Gene therapy
AU3444300A (en) Genetic analysis
EP1182256A4 (en) WITH POLLINOSIS ASSOCIATED GEN 513
GB9810997D0 (en) Genes & enzymes
AU5524899A (en) Human deltex-like gene zdx
GB9927520D0 (en) Genetic analysis
GB9602387D0 (en) Insect gene mutation
AU2001263307A8 (en) Haplotypes of the ccr3 gene
GB9819721D0 (en) Novel gene
GB9903122D0 (en) Novel gene